Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Breast Cancer

  Free Subscription


Articles published in Breast Cancer

Retrieve available abstracts of 299 articles:
HTML format



Single Articles


    November 2020
  1. SAWAKI M, Yamada A, Kumamaru H, Miyata H, et al
    Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan.
    Breast Cancer. 2020 Nov 21. pii: 10.1007/s12282-020-01188.
    PubMed     Abstract available


  2. KAWADA K, Taira N, Mizoo T, Suzuki Y, et al
    Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
    Breast Cancer. 2020 Nov 13. pii: 10.1007/s12282-020-01185.
    PubMed     Abstract available


  3. NOGUCHI M, Inokuchi M, Noguchi M, Morioka E, et al
    Axillary surgery for breast cancer: past, present, and future.
    Breast Cancer. 2020 Nov 9. pii: 10.1007/s12282-020-01120.
    PubMed     Abstract available


  4. BAN K, Tsunoda H, Togashi S, Kawaguchi Y, et al
    Breast cancer screening using digital breast tomosynthesis compared to digital mammography alone for Japanese women.
    Breast Cancer. 2020 Nov 9. pii: 10.1007/s12282-020-01180.
    PubMed     Abstract available


  5. YU X, Guo J, Zhou Q, Huang W, et al
    A novel immune-related prognostic index for predicting breast cancer overall survival.
    Breast Cancer. 2020 Nov 4. pii: 10.1007/s12282-020-01175.
    PubMed     Abstract available


  6. TANG L, Ma Z, Ishikawa Y, Matsushita H, et al
    Effect of radiotherapy after breast-conserving surgery in elderly patients with early breast cancer according to the AJCC 8th Edition Breast Cancer Staging System in Japan.
    Breast Cancer. 2020 Nov 3. pii: 10.1007/s12282-020-01181.
    PubMed     Abstract available


    October 2020
  7. PRIYADARSHINI R, Raj GM, Sundaram R, Kayal S, et al
    Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo-adjuvant chemotherapy.
    Breast Cancer. 2020 Oct 30. pii: 10.1007/s12282-020-01177.
    PubMed     Abstract available


  8. SAKAMOTO N, Nashimoto M, Nakagawa M, Haruyama Y, et al
    Skin grafting utilizing a skin of lateral thoracic area for chest wall reconstruction in patient who underwent mastectomy for locally advanced breast cancer.
    Breast Cancer. 2020 Oct 30. pii: 10.1007/s12282-020-01173.
    PubMed     Abstract available


  9. SHIMA H, Okuno T, Nakamura T, Noro A, et al
    Comparing the extent of breast cancer tumors through contrast-enhanced ultrasound vs B-mode, opposed with pathology: evergreen study.
    Breast Cancer. 2020 Oct 29. pii: 10.1007/s12282-020-01176.
    PubMed     Abstract available


  10. PENG R, Cao J, Guo Q, Sun Q, et al
    Variant in BCAR4 gene correlated with the breast cancer susceptibility and mRNA expression of lncRNA BCAR4 in Chinese Han population.
    Breast Cancer. 2020 Oct 28. pii: 10.1007/s12282-020-01174.
    PubMed     Abstract available


  11. LIAN B, Li H, Liu Y, Chai D, et al
    Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.
    Breast Cancer. 2020 Oct 27. pii: 10.1007/s12282-020-01179.
    PubMed     Abstract available


  12. MASUDA N, Mukai H, Inoue K, Rai Y, et al
    Analysis of subsequent therapy in Japanese patients with hormone receptorpositive/human epidermal growth factor receptor 2negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3.
    Breast Cancer. 2020 Oct 21. pii: 10.1007/s12282-020-01162.
    PubMed     Abstract available


  13. LIANG H, Zhou G, Lv L, Lu J, et al
    KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer.
    Breast Cancer. 2020 Oct 16. pii: 10.1007/s12282-020-01170.
    PubMed     Abstract available


  14. LING Y, Cao Q, Liu Y, Zhao J, et al
    Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
    Breast Cancer. 2020 Oct 12. pii: 10.1007/s12282-020-01169.
    PubMed     Abstract available


  15. LAO C, Kuper-Hommel M, Elwood M, Campbell I, et al
    Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand.
    Breast Cancer. 2020 Oct 12. pii: 10.1007/s12282-020-01171.
    PubMed     Abstract available


  16. HSU YH, Chen VC, Hsieh CC, Weng YP, et al
    Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
    Breast Cancer. 2020 Oct 8. pii: 10.1007/s12282-020-01168.
    PubMed     Abstract available


    September 2020
  17. BANDEIRA G, Rocha K, Lazar M, Ezquina S, et al
    Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer.
    Breast Cancer. 2020 Sep 28. pii: 10.1007/s12282-020-01165.
    PubMed     Abstract available


  18. ONISHI N, Kataoka M
    Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies.
    Breast Cancer. 2020 Sep 21. pii: 10.1007/s12282-020-01157.
    PubMed     Abstract available


  19. AHMED M
    Optimizing breast cancer surgery during the COVID-19 pandemic.
    Breast Cancer. 2020 Sep 18. pii: 10.1007/s12282-020-01160.
    PubMed     Abstract available


  20. ZHAO JM, An Q, Sun CN, Li YB, et al
    Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
    Breast Cancer. 2020 Sep 17. pii: 10.1007/s12282-020-01158.
    PubMed     Abstract available


  21. FUJII T, Ichiba K, Honda C, Tokuda S, et al
    Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patients.
    Breast Cancer. 2020 Sep 17. pii: 10.1007/s12282-020-01161.
    PubMed     Abstract available


  22. VUKSANOVIC D, Sanmugarajah J, Lunn D, Sawhney R, et al
    Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project.
    Breast Cancer. 2020 Sep 14. pii: 10.1007/s12282-020-01156.
    PubMed     Abstract available


  23. ALATAWI Y, Hansen RA, Chou C, Qian J, et al
    The impact of cognitive impairment on survival and medication adherence among older women with breast cancer.
    Breast Cancer. 2020 Sep 9. pii: 10.1007/s12282-020-01155.
    PubMed     Abstract available


  24. AKRIDA I, Argentou MI
    Correction to: Letter to the Editor: comment on 'Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient's perspective' by Elfgen et al.
    Breast Cancer. 2020 Sep 8. pii: 10.1007/s12282-020-01154.
    PubMed     Abstract available


  25. ROGOZA-JANISZEWSKA E, Malinska K, Gorski B, Scott RJ, et al
    Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population.
    Breast Cancer. 2020 Sep 4. pii: 10.1007/s12282-020-01151.
    PubMed     Abstract available


    August 2020
  26. OGATA R, Kishino E, Saitoh W, Koike Y, et al
    Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells.
    Breast Cancer. 2020 Aug 28. pii: 10.1007/s12282-020-01150.
    PubMed     Abstract available


  27. LOPEZ P, Galvao DA, Taaffe DR, Newton RU, et al
    Resistance training in breast cancer patients undergoing primary treatment: a systematic review and meta-regression of exercise dosage.
    Breast Cancer. 2020 Aug 19. pii: 10.1007/s12282-020-01147.
    PubMed     Abstract available


  28. ISHIDA K, Ohnuki K, Usami S, Komatsu H, et al
    A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan.
    Breast Cancer. 2020 Aug 13. pii: 10.1007/s12282-020-01144.
    PubMed     Abstract available


  29. ZHONG W, Yang Y, Zhang A, Lin W, et al
    Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer.
    Breast Cancer. 2020 Aug 11. pii: 10.1007/s12282-020-01142.
    PubMed     Abstract available


    July 2020
  30. IOANNA A, Maria-Ioanna A
    Letter to the Editor: comment on 'Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient's perspective' by Elfgen et al.
    Breast Cancer. 2020 Jul 31. pii: 10.1007/s12282-020-01143.
    PubMed     Abstract available


  31. VANNI G, Pellicciaro M, Materazzo M, Dauri M, et al
    Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency.
    Breast Cancer. 2020 Jul 30. pii: 10.1007/s12282-020-01137.
    PubMed     Abstract available


  32. WAAIJER L, Filipe MD, Simons J, van der Pol CC, et al
    Detection of breast cancer precursor lesions by autofluorescence ductoscopy.
    Breast Cancer. 2020 Jul 28. pii: 10.1007/s12282-020-01136.
    PubMed     Abstract available


  33. YOSHIDA-ICHIKAWA Y, Horimoto Y, Shikama N, Yanagisawa N, et al
    Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
    Breast Cancer. 2020 Jul 27. pii: 10.1007/s12282-020-01134.
    PubMed     Abstract available


  34. YAMAMOTO Y, Yamashiro H, Toh U, Kondo N, et al
    Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.
    Breast Cancer. 2020 Jul 26. pii: 10.1007/s12282-020-01138.
    PubMed     Abstract available


  35. MISIR S, Hepokur C, Aliyazicioglu Y, Enguita FJ, et al
    Circular RNAs serve as miRNA sponges in breast cancer.
    Breast Cancer. 2020 Jul 26. pii: 10.1007/s12282-020-01140.
    PubMed     Abstract available


  36. HAYASHI N, Kumamaru H, Isozumi U, Aogi K, et al
    Annual report of the Japanese Breast Cancer Registry for 2017.
    Breast Cancer. 2020 Jul 24. pii: 10.1007/s12282-020-01139.
    PubMed     Abstract available


  37. MOSS JL, Tatalovich Z, Zhu L, Morgan C, et al
    Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors.
    Breast Cancer. 2020 Jul 15. pii: 10.1007/s12282-020-01132.
    PubMed     Abstract available


  38. YANG KL, Khoo BY, Ong MT, Yoong ICK, et al
    In vitro anti-breast cancer studies of LED red light therapy through autophagy.
    Breast Cancer. 2020 Jul 11. pii: 10.1007/s12282-020-01128.
    PubMed     Abstract available


  39. OKAZAKI M, Bando H, Tohno E, Kujiraoka Y, et al
    Investigation of the significance of population-based breast cancer screening among women aged under 40 years.
    Breast Cancer. 2020 Jul 8. pii: 10.1007/s12282-020-01131.
    PubMed     Abstract available


  40. TOZAKI M, Nakamura S
    Current status of breast cancer screening in high-risk women in Japan.
    Breast Cancer. 2020 Jul 6. pii: 10.1007/s12282-020-01103.
    PubMed     Abstract available


    June 2020
  41. CHONG F, Wang Y, Song M, Sun Q, et al
    Sedentary behavior and risk of breast cancer: a dose-response meta-analysis from prospective studies.
    Breast Cancer. 2020 Jun 30. pii: 10.1007/s12282-020-01126.
    PubMed     Abstract available


  42. TAJIRI W, Ijichi H, Takizawa K, Koi Y, et al
    The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
    Breast Cancer. 2020 Jun 29. pii: 10.1007/s12282-020-01130.
    PubMed     Abstract available


  43. TANAKA N, Hirano A, Hattori A, Ogura K, et al
    Effect of adjuvant chemotherapy in patients with ER + /HER2- breast cancer, assessed by propensity score matching: significance of nuclear grade and nodal status.
    Breast Cancer. 2020 Jun 26. pii: 10.1007/s12282-020-01125.
    PubMed     Abstract available


  44. BANDO H, Kataoka A, Tamaki K, Kobayashi M, et al
    Physician's knowledge, attitudes and practice pattern for breast cancer diagnosed during pregnancy: a survey among breast care specialists in Japan.
    Breast Cancer. 2020 Jun 26. pii: 10.1007/s12282-020-01118.
    PubMed     Abstract available


  45. BARTOLO A, Neves M, Carvalho B, Reis S, et al
    Fertility under uncertainty: exploring differences in fertility-related concerns and psychosocial aspects between breast cancer survivors and non-cancer infertile women.
    Breast Cancer. 2020 Jun 24. pii: 10.1007/s12282-020-01124.
    PubMed     Abstract available


  46. KAJIHARA N, Kitagawa F, Kobayashi T, Wada H, et al
    Interleukin-34 contributes to poor prognosis in triple-negative breast cancer.
    Breast Cancer. 2020 Jun 23. pii: 10.1007/s12282-020-01123.
    PubMed     Abstract available


  47. MALIK SS, Zia A, Rashid S, Mubarik S, et al
    XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis.
    Breast Cancer. 2020 Jun 19. pii: 10.1007/s12282-020-01121.
    PubMed     Abstract available


  48. TANAKA R, Yamagishi Y, Koiwai T, Kono T, et al
    Comparison between AJCC 8th prognostic stage and UICC anatomical stage in patients with primary breast cancer: a single institutional retrospective study.
    Breast Cancer. 2020 Jun 3. pii: 10.1007/s12282-020-01115.
    PubMed     Abstract available


  49. LAMBERT M, Sabiston CM, Wrosch C, Brunet J, et al
    An investigation into socio-demographic-, health-, and cancer-related factors associated with cortisol and C-reactive protein levels in breast cancer survivors: a longitudinal study.
    Breast Cancer. 2020 Jun 1. pii: 10.1007/s12282-020-01113.
    PubMed     Abstract available


  50. ELFGEN C, Guth U, Gruber G, Birrer S, et al
    Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient's perspective.
    Breast Cancer. 2020 Jun 1. pii: 10.1007/s12282-020-01114.
    PubMed     Abstract available


    May 2020
  51. TOKUNAGA E, Ijichi H, Tajiri W, Masuda T, et al
    The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution.
    Breast Cancer. 2020 May 29. pii: 10.1007/s12282-020-01116.
    PubMed     Abstract available


  52. CANER A, Sadiqova A, Erdogan A, Namlises D, et al
    Targeting of antitumor immune responses with live-attenuated Leishmania strains in breast cancer model.
    Breast Cancer. 2020 May 29. pii: 10.1007/s12282-020-01112.
    PubMed     Abstract available


  53. DUAN S, Luo X, Zeng H, Zhan X, et al
    SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition.
    Breast Cancer. 2020 May 23. pii: 10.1007/s12282-020-01111.
    PubMed     Abstract available


  54. SUGIE T, Sato E, Miyashita M, Yamaguchi R, et al
    Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
    Breast Cancer. 2020 May 23. pii: 10.1007/s12282-020-01110.
    PubMed     Abstract available


  55. HORII R, Tsuda H, Masuda S, Sugita H, et al
    Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer.
    Breast Cancer. 2020 May 21. pii: 10.1007/s12282-020-01108.
    PubMed     Abstract available


  56. TSUDA H, Tsugawa K, Akiyama F, Horii R, et al
    Correction to: Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition).
    Breast Cancer. 2020 May 19. pii: 10.1007/s12282-020-01106.
    PubMed     Abstract available


  57. SHIZUKU M, Shibata M, Okumura M, Takeuchi D, et al
    Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases.
    Breast Cancer. 2020 May 15. pii: 10.1007/s12282-020-01109.
    PubMed     Abstract available


  58. KUBO M, Kumamaru H, Isozumi U, Miyashita M, et al
    Annual report of the Japanese Breast Cancer Society registry for 2016.
    Breast Cancer. 2020 May 11. pii: 10.1007/s12282-020-01081.
    PubMed     Abstract available


  59. IWAMOTO T, Fujisawa T, Shien T, Araki K, et al
    The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs.
    Breast Cancer. 2020 May 11. pii: 10.1007/s12282-020-01095.
    PubMed     Abstract available


  60. BALTRES A, Al Masry Z, Zemouri R, Valmary-Degano S, et al
    Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer.
    Breast Cancer. 2020 May 8. pii: 10.1007/s12282-020-01100.
    PubMed     Abstract available


  61. YUEN S, Monzawa S, Yanai S, Matsumoto H, et al
    The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images.
    Breast Cancer. 2020 May 6. pii: 10.1007/s12282-020-01105.
    PubMed     Abstract available


  62. KIM S, Lee S, Bae Y, Lee S, et al
    Nipple-sparing mastectomy for breast cancer close to the nipple: a single institution's 11-year experience.
    Breast Cancer. 2020 May 5. pii: 10.1007/s12282-020-01104.
    PubMed     Abstract available


  63. CHAO YH, Wang SY, Sheu SJ
    Integrative review of breast cancer survivors' transition experience and transitional care: dialog with transition theory perspectives.
    Breast Cancer. 2020 May 5. pii: 10.1007/s12282-020-01097.
    PubMed     Abstract available


  64. SEKINE H, Kijima Y, Kobayashi M, Itami J, et al
    Non-invasive quantitative measures of qualitative grading effectiveness as the indices of acute radiation dermatitis in breast cancer patients.
    Breast Cancer. 2020 May 3. pii: 10.1007/s12282-020-01082.
    PubMed     Abstract available


  65. XU Y, Zhang Z, Zhang L, Zhang C, et al
    Novel module and hub genes of distinctive breast cancer associated fibroblasts identified by weighted gene co-expression network analysis.
    Breast Cancer. 2020 May 1. pii: 10.1007/s12282-020-01101.
    PubMed     Abstract available


    April 2020
  66. TAKANO T
    The era of meta-analyses-based recommendations: how were the Japanese Breast Cancer Society Clinical Practice Guidelines for Systemic Treatment of Breast Cancer established?
    Breast Cancer. 2020 Apr 27. pii: 10.1007/s12282-020-01099.
    PubMed    


  67. LU Y, Yang G, Xiao Y, Zhang T, et al
    Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
    Breast Cancer. 2020 Apr 27. pii: 10.1007/s12282-020-01086.
    PubMed     Abstract available


  68. ALKARAKI A, Alshaer W, Wehaibi S, Gharaibeh L, et al
    Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and beta-catenin genes.
    Breast Cancer. 2020 Apr 23. pii: 10.1007/s12282-020-01098.
    PubMed     Abstract available


  69. DAN J, Tan J, Huang J, Zhang X, et al
    The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
    Breast Cancer. 2020 Apr 18. pii: 10.1007/s12282-020-01096.
    PubMed     Abstract available


  70. DENDA Y, Niikura N, Satoh-Kuriwada S, Yokoyama K, et al
    Taste alterations in patients with breast cancer following chemotherapy: a cohort study.
    Breast Cancer. 2020 Apr 16. pii: 10.1007/s12282-020-01089.
    PubMed     Abstract available


  71. TONG T, Lu H, Zong J, Lv Q, et al
    Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis.
    Breast Cancer. 2020 Apr 16. pii: 10.1007/s12282-020-01094.
    PubMed     Abstract available


  72. OSHIRO C, Yamasaki M, Noda Y, Nishimae A, et al
    Comparative evaluation of nuclear and histological grades as prognostic factors for invasive breast cancer.
    Breast Cancer. 2020 Apr 15. pii: 10.1007/s12282-020-01093.
    PubMed     Abstract available


  73. ISAKOVA JT, Vinnikov D, Kipen VN, Talaibekova ET, et al
    Gene-to-gene interactions and the association of TP53, XRCC1, TNFalpha, HMMR, MDM2 and PALB2 with breast cancer in Kyrgyz females.
    Breast Cancer. 2020 Apr 15. pii: 10.1007/s12282-020-01092.
    PubMed     Abstract available


  74. PAN XF, Ma YJ, Tang Y, Yu MM, et al
    Breast cancer populations may have an increased prevalence of thyroglobulin antibody and thyroid peroxidase antibody: a systematic review and meta-analysis.
    Breast Cancer. 2020 Apr 11. pii: 10.1007/s12282-020-01078.
    PubMed     Abstract available


  75. AOISHI Y, Oura S, Nishiguchi H, Hirai Y, et al
    Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
    Breast Cancer. 2020 Apr 8. pii: 10.1007/s12282-020-01088.
    PubMed     Abstract available


  76. FARBOOD A, Sahmeddini MA, Bayat S, Karami N, et al
    The effect of preoperative depression and anxiety on heart rate variability in women with breast cancer.
    Breast Cancer. 2020 Apr 7. pii: 10.1007/s12282-020-01087.
    PubMed     Abstract available


  77. SHIMOI T, Nagai SE, Yoshinami T, Takahashi M, et al
    The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
    Breast Cancer. 2020 Apr 2. pii: 10.1007/s12282-020-01085.
    PubMed     Abstract available


    March 2020
  78. SOLIS-CASTILLO LA, Garcia-Romo GS, Diaz-Rodriguez A, Reyes-Hernandez D, et al
    Tumor-infiltrating regulatory T cells, CD8/Treg ratio, and cancer stem cells are correlated with lymph node metastasis in patients with early breast cancer.
    Breast Cancer. 2020 Mar 16. pii: 10.1007/s12282-020-01079.
    PubMed     Abstract available


  79. ZEHRA S, Doyle F, Barry M, Walsh S, et al
    Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis.
    Breast Cancer. 2020 Mar 12. pii: 10.1007/s12282-020-01076.
    PubMed     Abstract available


  80. TSUDA H
    Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition).
    Breast Cancer. 2020 Mar 9. pii: 10.1007/s12282-020-01074.
    PubMed     Abstract available


  81. KHALIS M, Dossus L, Rinaldi S, Biessy C, et al
    Body size, silhouette trajectory and the risk of breast cancer in a Moroccan case-control study.
    Breast Cancer. 2020 Mar 6. pii: 10.1007/s12282-020-01072.
    PubMed     Abstract available


  82. WANG X, Zhou X, Zeng F, Wu X, et al
    miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
    Breast Cancer. 2020 Mar 6. pii: 10.1007/s12282-020-01075.
    PubMed     Abstract available


  83. MATSUNUMA R, Watanabe T, Hozumi Y, Koizumi K, et al
    Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer.
    Breast Cancer. 2020 Mar 6. pii: 10.1007/s12282-020-01077.
    PubMed     Abstract available


  84. GOTO Y, Tsugawa K, Furuya Y, Maezato M, et al
    Behavior of Japanese women after being informed about the benefits and disadvantages of breast cancer screening: a questionnaire survey.
    Breast Cancer. 2020 Mar 5. pii: 10.1007/s12282-020-01071.
    PubMed     Abstract available


  85. MIYOSHI Y, Yoshimura Y, Saito K, Muramoto K, et al
    High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin-but not with treatment of physician's choice-in the EMBRACE study.
    Breast Cancer. 2020 Mar 5. pii: 10.1007/s12282-020-01067.
    PubMed     Abstract available


  86. OKUMURA S, Hyodo I, Iwata H, Kamei Y, et al
    Immediate one-stage implant-based breast reconstruction without the use of acellular dermal matrix in Japanese breast cancer patients.
    Breast Cancer. 2020 Mar 4. pii: 10.1007/s12282-020-01073.
    PubMed     Abstract available


  87. VURAL V, Yilmaz OC
    The Turkish SentiMAG feasibility trial: preliminary results.
    Breast Cancer. 2020;27:261-265.
    PubMed     Abstract available


  88. WADASADAWALA T, Sinha S, Parmar V, Verma S, et al
    Comparison of subjective, objective and patient-reported cosmetic outcomes between accelerated partial breast irradiation and whole breast radiotherapy: a prospective propensity score-matched pair analysis.
    Breast Cancer. 2020;27:206-212.
    PubMed     Abstract available


  89. SOROR T, Lancellotta V, Kovacs G, Lanzotti V, et al
    kOBCS((c)): a novel software calculator program of the Objective Breast Cosmesis Scale (OBCS).
    Breast Cancer. 2020;27:179-185.
    PubMed     Abstract available


    February 2020
  90. MANGONE L, Ferrari F, Mancuso P, Carrozzi G, et al
    Epidemiology and biological characteristics of male breast cancer in Italy.
    Breast Cancer. 2020 Feb 29. pii: 10.1007/s12282-020-01068.
    PubMed     Abstract available


  91. YAMAMOTO S, Masutani E, Arao H
    Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy.
    Breast Cancer. 2020 Feb 29. pii: 10.1007/s12282-020-01062.
    PubMed     Abstract available


  92. JYLLING AMB, Jensen V, Lelkaitis G, Christiansen P, et al
    Male breast cancer: clinicopathological characterization of a National Danish cohort 1980-2009.
    Breast Cancer. 2020 Feb 27. pii: 10.1007/s12282-020-01066.
    PubMed     Abstract available


  93. MYOJIN M, Horimoto Y, Ito M, Kitano S, et al
    Neutrophil-to-lymphocyte ratio and histological type might predict clinical responses to eriburin-based treatment in patients with metastatic breast cancer.
    Breast Cancer. 2020 Feb 27. pii: 10.1007/s12282-020-01069.
    PubMed     Abstract available


  94. OHISHI Y, Mitsuda A, Ejima K, Morizono H, et al
    Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient.
    Breast Cancer. 2020 Feb 24. pii: 10.1007/s12282-020-01064.
    PubMed     Abstract available


  95. SEMAAN J, El-Hakim S, Ibrahim JN, Safi R, et al
    Comparative effect of sodium butyrate and sodium propionate on proliferation, cell cycle and apoptosis in human breast cancer cells MCF-7.
    Breast Cancer. 2020 Feb 24. pii: 10.1007/s12282-020-01063.
    PubMed     Abstract available


  96. SAFABAKHSH M, Imani H, Shab-Bidar S
    Higher dietary total antioxidant capacity is not associated with risk of breast cancer in Iranian women.
    Breast Cancer. 2020 Feb 17. pii: 10.1007/s12282-020-01059.
    PubMed     Abstract available


  97. YAMASHIRO H, Iwata H, Masuda N, Yamamoto N, et al
    Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.
    Breast Cancer. 2020 Feb 14. pii: 10.1007/s12282-020-01057.
    PubMed     Abstract available


  98. MILLER EA, Pinsky PF, Heckman-Stoddard BM, Minasian LM, et al
    Breast cancer risk prediction models and subsequent tumor characteristics.
    Breast Cancer. 2020 Feb 13. pii: 10.1007/s12282-020-01060.
    PubMed     Abstract available


  99. SASAKI M, Tozaki M, Rodriguez-Ruiz A, Yotsumoto D, et al
    Artificial intelligence for breast cancer detection in mammography: experience of use of the ScreenPoint Medical Transpara system in 310 Japanese women.
    Breast Cancer. 2020 Feb 12. pii: 10.1007/s12282-020-01061.
    PubMed     Abstract available


  100. SHIMOI T, Sagara Y, Hara F, Toyama T, et al
    First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis.
    Breast Cancer. 2020 Feb 11. pii: 10.1007/s12282-020-01054.
    PubMed     Abstract available


  101. LI J, Liu L, Feng Z, Wang X, et al
    Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study.
    Breast Cancer. 2020 Feb 10. pii: 10.1007/s12282-020-01058.
    PubMed     Abstract available


  102. MAROUFI NF, Vahedian V, Akbarzadeh M, Mohammadian M, et al
    The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-kappaB (NF-kappaB) and mitogen-activated protein kinase (MAPK) signaling pathways.
    Breast Cancer. 2020 Feb 5. pii: 10.1007/s12282-020-01055.
    PubMed     Abstract available


    January 2020
  103. GOHARA T, Komura M, Asano A, Emura T, et al
    A case of secretory breast cancer in a 6 year-old girl: is it possible to make a correct preoperative diagnosis?
    Breast Cancer. 2020 Jan 30. pii: 10.1007/s12282-020-01056.
    PubMed     Abstract available


  104. LINGRAND M, Lalonde S, Jutras-Carignan A, Bergeron KF, et al
    SCD1 activity promotes cell migration via a PLD-mTOR pathway in the MDA-MB-231 triple-negative breast cancer cell line.
    Breast Cancer. 2020 Jan 29. pii: 10.1007/s12282-020-01053.
    PubMed     Abstract available


  105. MIYASHITA M, Hattori M, Takano T, Toyama T, et al
    Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials.
    Breast Cancer. 2020 Jan 23. pii: 10.1007/s12282-020-01052.
    PubMed     Abstract available


  106. ZHANG Y, Li Z, Chen M, Chen H, et al
    lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
    Breast Cancer. 2020 Jan 20. pii: 10.1007/s12282-020-01048.
    PubMed     Abstract available


  107. HUANG M, Wu J, Ling R, Li N, et al
    Quadruple negative breast cancer.
    Breast Cancer. 2020 Jan 14. pii: 10.1007/s12282-020-01047.
    PubMed     Abstract available


  108. GOTO R, Hirota Y, Aruga T, Horiguchi S, et al
    The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer.
    Breast Cancer. 2020 Jan 13. pii: 10.1007/s12282-020-01049.
    PubMed     Abstract available


  109. LIU Y, Wang J, Su R, Tang Y, et al
    Postoperative radiotherapy-induced leiomyosarcoma in breast cancer: a case report and literature review.
    Breast Cancer. 2020 Jan 11. pii: 10.1007/s12282-020-01050.
    PubMed     Abstract available


  110. ZHANG L, Zhang X, Zhang H, Liu F, et al
    Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
    Breast Cancer. 2020 Jan 9. pii: 10.1007/s12282-020-01045.
    PubMed     Abstract available


  111. CHANG YK, Co M, Kwong A
    Conversion rate from mastectomy to breast conservation after neoadjuvant dual target therapy for HER2-positive breast cancer in the Asian population.
    Breast Cancer. 2020 Jan 8. pii: 10.1007/s12282-019-01037.
    PubMed     Abstract available


  112. YOSHINAMI T, Koizumi K, Nagai SE, Toyama T, et al
    Dose-dense adjuvant chemotherapy: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2018 edition.
    Breast Cancer. 2020 Jan 8. pii: 10.1007/s12282-019-01039.
    PubMed     Abstract available


  113. KURATA K, Kubo M, Kai M, Mori H, et al
    Microsatellite instability in Japanese female patients with triple-negative breast cancer.
    Breast Cancer. 2020 Jan 6. pii: 10.1007/s12282-019-01043.
    PubMed     Abstract available


  114. ACUN T, Senses KM
    Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer.
    Breast Cancer. 2020 Jan 4. pii: 10.1007/s12282-019-01042.
    PubMed     Abstract available


  115. WANG B, Zhu L, He C, Tai M, et al
    Growth pattern can be used as a new characteristic to predict malignancy in breast cancer.
    Breast Cancer. 2020 Jan 3. pii: 10.1007/s12282-019-01041.
    PubMed     Abstract available


  116. BLOCKHUYS S, Brady DC, Wittung-Stafshede P
    Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer.
    Breast Cancer. 2020 Jan 2. pii: 10.1007/s12282-019-01044.
    PubMed     Abstract available


  117. HE C, Kawaguchi K, Toi M
    DNA damage repair functions and targeted treatment in breast cancer.
    Breast Cancer. 2020 Jan 2. pii: 10.1007/s12282-019-01038.
    PubMed     Abstract available


  118. TOPALOGLU US, Ozaslan E
    Comorbidity and polypharmacy in patients with breast cancer.
    Breast Cancer. 2020 Jan 2. pii: 10.1007/s12282-019-01040.
    PubMed     Abstract available


  119. IZUMORI A, Kokubu Y, Sato K, Gomi N, et al
    Usefulness of second-look ultrasonography using anatomical breast structures as indicators for magnetic resonance imaging-detected breast abnormalities.
    Breast Cancer. 2020;27:129-139.
    PubMed     Abstract available


  120. YOU C, Zhang Y, Gu Y, Xiao Q, et al
    Comparison of the diagnostic performance of synthesized two-dimensional mammography and full-field digital mammography alone or in combination with digital breast tomosynthesis.
    Breast Cancer. 2020;27:47-53.
    PubMed     Abstract available


  121. NAGURA N, Hayashi N, Takei J, Yoshida A, et al
    Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers.
    Breast Cancer. 2020;27:70-76.
    PubMed     Abstract available


    December 2019
  122. LIAO W, Huang J, Wu Q, Wen F, et al
    First-line fulvestrant plus anastrozole for hormone-receptor-positive metastatic breast cancer in postmenopausal women: a cost-effectiveness analysis.
    Breast Cancer. 2019 Dec 18. pii: 10.1007/s12282-019-01034.
    PubMed     Abstract available


  123. INOKUCHI M, Kutomi G, Kijima Y, Sakai T, et al
    The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition.
    Breast Cancer. 2019 Dec 12. pii: 10.1007/s12282-019-01030.
    PubMed     Abstract available


  124. HASHEMI SM, Rafiemanesh H, Aghamohammadi T, Badakhsh M, et al
    Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis.
    Breast Cancer. 2019 Dec 11. pii: 10.1007/s12282-019-01031.
    PubMed     Abstract available


  125. KISHINO E, Ogata R, Saitoh W, Koike Y, et al
    Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells.
    Breast Cancer. 2019 Dec 10. pii: 10.1007/s12282-019-01035.
    PubMed     Abstract available


  126. KAWAGUCHI H, Masuda N, Nakayama T, Aogi K, et al
    Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study.
    Breast Cancer. 2019 Dec 6. pii: 10.1007/s12282-019-01029.
    PubMed     Abstract available


  127. KILLELEA BK, Herrin J, Soulos PR, Pollack CE, et al
    Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups.
    Breast Cancer. 2019 Dec 2. pii: 10.1007/s12282-019-01028.
    PubMed     Abstract available


    November 2019
  128. LIU H, Sun H, Zhang B, Liu S, et al
    (18)F-FDG PET imaging for monitoring the early anti-tumor effect of albendazole on triple-negative breast cancer.
    Breast Cancer. 2019 Nov 28. pii: 10.1007/s12282-019-01027.
    PubMed     Abstract available


  129. YANG JR, Shao YC
    Everolimus-associated cytomegalovirus colitis in a patient with metastasized breast cancer: a case report.
    Breast Cancer. 2019 Nov 26. pii: 10.1007/s12282-019-01026.
    PubMed     Abstract available


  130. IWATA H, Saji S, Ikeda M, Inokuchi M, et al
    The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient.
    Breast Cancer. 2019 Nov 22. pii: 10.1007/s12282-019-01021.
    PubMed     Abstract available


  131. UEMATSU T, Nakashima K, Kikuchi M, Kubota K, et al
    The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition.
    Breast Cancer. 2019 Nov 16. pii: 10.1007/s12282-019-01025.
    PubMed     Abstract available


  132. LI K, Pan WT, Ma YB, Xu XL, et al
    BMX activates Wnt/beta-catenin signaling pathway to promote cell proliferation and migration in breast cancer.
    Breast Cancer. 2019 Nov 14. pii: 10.1007/s12282-019-01024.
    PubMed     Abstract available


  133. MA J, Zhou Z
    Downregulation of miR-302b is associated with poor prognosis and tumor progression of breast cancer.
    Breast Cancer. 2019 Nov 13. pii: 10.1007/s12282-019-01022.
    PubMed     Abstract available


  134. LAI J, Hu S, Luo Y, Zheng R, et al
    Meta-analysis of deep inspiration breath hold (DIBH) versus free breathing (FB) in postoperative radiotherapy for left-side breast cancer.
    Breast Cancer. 2019 Nov 9. pii: 10.1007/s12282-019-01023.
    PubMed     Abstract available


  135. WANG X, Luo J, Jin K, Chen X, et al
    Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
    Breast Cancer. 2019 Nov 6. pii: 10.1007/s12282-019-01015.
    PubMed     Abstract available


  136. AKEZAKI Y, Nakata E, Kikuuchi M, Tominaga R, et al
    Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection.
    Breast Cancer. 2019 Nov 2. pii: 10.1007/s12282-019-01020.
    PubMed     Abstract available


    October 2019
  137. YAMAUCHI C, Yoshimura M, Sekiguchi K, Hamamoto Y, et al
    The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition.
    Breast Cancer. 2019 Oct 28. pii: 10.1007/s12282-019-01019.
    PubMed     Abstract available


  138. CHRISTENSEN TD, Buhl ASK, Christensen IJ, Buhl IK, et al
    Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay.
    Breast Cancer. 2019 Oct 25. pii: 10.1007/s12282-019-01017.
    PubMed     Abstract available


  139. NISHIYAMA K, Taira N, Mizoo T, Kochi M, et al
    Influence of breast density on breast cancer risk: a case control study in Japanese women.
    Breast Cancer. 2019 Oct 24. pii: 10.1007/s12282-019-01018.
    PubMed     Abstract available


  140. MIYAZAWA S, Moriya S, Kokuba H, Hino H, et al
    Vitamin K2 induces non-apoptotic cell death along with autophagosome formation in breast cancer cell lines.
    Breast Cancer. 2019 Oct 17. pii: 10.1007/s12282-019-01012.
    PubMed     Abstract available


  141. MIRZAEI-PARSA MJ, Najafabadi MRH, Haeri A, Zahmatkeshan M, et al
    Preparation, characterization, and evaluation of the anticancer activity of artemether-loaded nano-niosomes against breast cancer.
    Breast Cancer. 2019 Oct 16. pii: 10.1007/s12282-019-01014.
    PubMed     Abstract available


  142. SUZUKI H, Seki A, Hosaka T, Matsumoto N, et al
    Effects of a structured group intervention on obesity among breast cancer survivors.
    Breast Cancer. 2019 Oct 15. pii: 10.1007/s12282-019-01013.
    PubMed     Abstract available


    September 2019
  143. ZALLOUM H, AbuThiab T, Hameduh T, AlBayyari S, et al
    Comparative anti-proliferative effects of potential HER2 inhibitors on a panel of breast cancer cell lines.
    Breast Cancer. 2019 Sep 26. pii: 10.1007/s12282-019-01011.
    PubMed     Abstract available


  144. XIE BJ, Zhu LN, Ma C, Li JB, et al
    A network meta-analysis on the efficacy of HER2-targeted agents in combination with taxane-containing regimens for treatment of HER2-positive metastatic breast cancer.
    Breast Cancer. 2019 Sep 16. pii: 10.1007/s12282-019-01007.
    PubMed     Abstract available


  145. ANDIC F, Miller AH, Brown G, Chu L, et al
    Instruments for determining clinically relevant fatigue in breast cancer patients during radiotherapy.
    Breast Cancer. 2019 Sep 6. pii: 10.1007/s12282-019-01008.
    PubMed     Abstract available


    August 2019
  146. DE SOUZA CUNHA N, Zomkowski K, Fernandes BL, Sacomori C, et al
    Physical symptoms and components of labor tasks associated with upper limb disability among working breast cancer survivors.
    Breast Cancer. 2019 Aug 27. pii: 10.1007/s12282-019-01004.
    PubMed     Abstract available


  147. KAWASE K, Yamashita H, Iwase H, Akashi-Tanaka S, et al
    Current conditions and issues of physicians and working conditions at institutions accredited by the Japanese Breast Cancer Society.
    Breast Cancer. 2019 Aug 22. pii: 10.1007/s12282-019-01005.
    PubMed     Abstract available


  148. LIN QY, Wang JQ, Wu LL, Zheng WE, et al
    miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Breast Cancer. 2019 Aug 13. pii: 10.1007/s12282-019-01002.
    PubMed     Abstract available


  149. NAITO Y, Kai Y, Ishikawa T, Fujita T, et al
    Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study.
    Breast Cancer. 2019 Aug 12. pii: 10.1007/s12282-019-01001.
    PubMed     Abstract available


  150. ZHANG R, Gao P, Ding J, Li Z, et al
    Assessment of significant procedures in multigene molecular detection for breast cancer in clinical laboratories: from variant detection to targeted therapy.
    Breast Cancer. 2019 Aug 6. pii: 10.1007/s12282-019-01000.
    PubMed     Abstract available


  151. IIOKA Y, Iwata T, Yamauchi H
    Developing a checksheet for breast cancer patients receiving endocrine therapy-examining reliability and validity.
    Breast Cancer. 2019 Aug 2. pii: 10.1007/s12282-019-00998.
    PubMed     Abstract available


  152. IGUCHI-MANAKA A, Okumura G, Ichioka E, Kiyomatsu H, et al
    High expression of soluble CD155 in estrogen receptor-negative breast cancer.
    Breast Cancer. 2019 Aug 1. pii: 10.1007/s12282-019-00999.
    PubMed     Abstract available


    July 2019
  153. NAKAGAWA A, Fujimoto H, Nagashima T, Sangai T, et al
    Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edema.
    Breast Cancer. 2019 Jul 25. pii: 10.1007/s12282-019-00996.
    PubMed     Abstract available


  154. HOJO T, Masuda N, Iwamoto T, Niikura N, et al
    Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society.
    Breast Cancer. 2019 Jul 20. pii: 10.1007/s12282-019-00997.
    PubMed     Abstract available


  155. IIOKA Y, Iwata T, Yamauchi H
    Symptoms and QOL in breast cancer patients receiving hormone therapy in Japan.
    Breast Cancer. 2019 Jul 11. pii: 10.1007/s12282-019-00993.
    PubMed     Abstract available


  156. MOON G, Noh H, Cho IJ, Lee JI, et al
    Prediction of late recurrence in patients with breast cancer: elevated neutrophil to lymphocyte ratio (NLR) at 5 years after diagnosis and late recurrence.
    Breast Cancer. 2019 Jul 6. pii: 10.1007/s12282-019-00994.
    PubMed     Abstract available


  157. YAO Z, Zheng X, Lu S, He Z, et al
    Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
    Breast Cancer. 2019 Jul 1. pii: 10.1007/s12282-019-00991.
    PubMed     Abstract available


    June 2019
  158. FURLANETTO J, von Minckwitz G, Lederer B, Mobus V, et al
    Fatal events during clinical trials: an evaluation of deaths during breast cancer studies.
    Breast Cancer. 2019 Jun 28. pii: 10.1007/s12282-019-00990.
    PubMed     Abstract available


  159. ZHAO C, Ling X, Li X, Hou X, et al
    MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
    Breast Cancer. 2019 Jun 26. pii: 10.1007/s12282-019-00989.
    PubMed     Abstract available


  160. ZHAI Q, Li H, Sun L, Yuan Y, et al
    Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Breast Cancer. 2019 Jun 13. pii: 10.1007/s12282-019-00988.
    PubMed     Abstract available


  161. DORRI S, Asadi F, Olfatbakhsh A, Kazemi A, et al
    A Systematic Review of Electronic Health (eHealth) interventions to improve physical activity in patients with breast cancer.
    Breast Cancer. 2019 Jun 12. pii: 10.1007/s12282-019-00982.
    PubMed     Abstract available


  162. SHIMIZU C, Sakata Y, Sakai R, Ikezawa H, et al
    Pharmacotherapy decision-making among patients with breast cancer in Japan: results of an online survey.
    Breast Cancer. 2019 Jun 8. pii: 10.1007/s12282-019-00986.
    PubMed     Abstract available


  163. SEKI H, Sakurai T, Mizuno S, Tokuda T, et al
    A novel nipple-areola complex involvement predictive index for indicating nipple-sparing mastectomy in breast cancer patients.
    Breast Cancer. 2019 Jun 8. pii: 10.1007/s12282-019-00987.
    PubMed     Abstract available


  164. CHENG X, Tan S, Duan F, Yuan Q, et al
    Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM.
    Breast Cancer. 2019 Jun 6. pii: 10.1007/s12282-019-00980.
    PubMed     Abstract available


  165. MASUDA N, Mukai H, Inoue K, Rai Y, et al
    Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
    Breast Cancer. 2019 Jun 5. pii: 10.1007/s12282-019-00984.
    PubMed     Abstract available


  166. BEYAN C, Beyan E
    Mean platelet volume may not be an independent prognostic factor in breast cancer patients with type 2 diabetes mellitus.
    Breast Cancer. 2019 Jun 3. pii: 10.1007/s12282-019-00983.
    PubMed    


    May 2019
  167. HAO R, Liu Y, Du Q, Liu L, et al
    Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.
    Breast Cancer. 2019 May 29. pii: 10.1007/s12282-019-00981.
    PubMed     Abstract available


  168. MANFUKU M, Nishigami T, Mibu A, Tanaka K, et al
    Comparison of central sensitization-related symptoms and health-related quality of life between breast cancer survivors with and without chronic pain and healthy controls.
    Breast Cancer. 2019 May 24. pii: 10.1007/s12282-019-00979.
    PubMed     Abstract available


  169. MASUDA N, Mukai H, Inoue K, Rai Y, et al
    Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
    Breast Cancer. 2019 May 24. pii: 10.1007/s12282-019-00970.
    PubMed     Abstract available


  170. TSUBOI K, Uematsu C, Yamaguchi Y, Niwa T, et al
    Tumor microenvironmental growth factors induce long-term estrogen deprivation resistance in breast cancer.
    Breast Cancer. 2019 May 22. pii: 10.1007/s12282-019-00978.
    PubMed     Abstract available


  171. USISKIN I, Li F, Irwin ML, Cartmel B, et al
    Association between pre-diagnosis BMI, physical activity, pathologic complete response, and chemotherapy completion in women treated with neoadjuvant chemotherapy for breast cancer.
    Breast Cancer. 2019 May 22. pii: 10.1007/s12282-019-00974.
    PubMed     Abstract available


  172. JONES LM, Stoner L, Brown C, Baldi JC, et al
    Cardiorespiratory fitness predicts cardiovascular health in breast cancer survivors, independent of body composition, age and time post-treatment completion.
    Breast Cancer. 2019 May 13. pii: 10.1007/s12282-019-00975.
    PubMed     Abstract available


  173. LI N, Lv XH, Wang X, Wang RT, et al
    Preoperative mean platelet volume predicts survival in breast cancer patients with type 2 diabetes.
    Breast Cancer. 2019 May 13. pii: 10.1007/s12282-019-00976.
    PubMed     Abstract available


  174. ROBERTSON JFR, Jiang Z, Di Leo A, Ohno S, et al
    A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer.
    Breast Cancer. 2019 May 11. pii: 10.1007/s12282-019-00973.
    PubMed     Abstract available


    April 2019
  175. MINAMI Y, Nishino Y, Kawai M, Tada H, et al
    Reproductive history and breast cancer survival: a prospective patient cohort study in Japan.
    Breast Cancer. 2019 Apr 15. pii: 10.1007/s12282-019-00972.
    PubMed     Abstract available


  176. GAO X, Liu X, Lu Y, Wang Y, et al
    PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
    Breast Cancer. 2019 Apr 15. pii: 10.1007/s12282-019-00966.
    PubMed     Abstract available


  177. SHIMADA S, Yoshida R, Nakashima E, Kitagawa D, et al
    Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
    Breast Cancer. 2019 Apr 12. pii: 10.1007/s12282-019-00971.
    PubMed     Abstract available


  178. PAPANIKOLAOU IG, Dimitrakakis C, Zagouri F, Marinopoulos S, et al
    Paving the way for changing perceptions in breast surgery: a systematic literature review focused on oncological and aesthetic outcomes of oncoplastic surgery for breast cancer.
    Breast Cancer. 2019 Apr 6. pii: 10.1007/s12282-019-00968.
    PubMed     Abstract available


  179. OMORI Y, Enatsu S, Cai Z, Ishiguro H, et al
    Patients' preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan.
    Breast Cancer. 2019 Apr 4. pii: 10.1007/s12282-019-00965.
    PubMed     Abstract available


  180. KATO F, Kudo K, Yamashita H, Baba M, et al
    Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer.
    Breast Cancer. 2019 Apr 1. pii: 10.1007/s12282-019-00969.
    PubMed     Abstract available


    March 2019
  181. LEE A, Jo S, Lee C, Shin HH, et al
    Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy.
    Breast Cancer. 2019 Mar 29. pii: 10.1007/s12282-019-00967.
    PubMed     Abstract available


  182. HIRAOKA E, Mimae T, Ito M, Kadoya T, et al
    Correction to: Breast cancer cell motility is promoted by 14-3-3gamma.
    Breast Cancer. 2019 Mar 29. pii: 10.1007/s12282-019-00964.
    PubMed     Abstract available


  183. PAN L, Ye C, Chen L, Tang W, et al
    Oncologic outcomes and radiation safety of nipple-sparing mastectomy with intraoperative radiotherapy for breast cancer.
    Breast Cancer. 2019 Mar 19. pii: 10.1007/s12282-019-00962.
    PubMed     Abstract available


  184. KYRIAZOGLOU A, Zagouri F, Fotiou D, Dimitrakakis C, et al
    Discrepancies of current recommendations in breast cancer follow-up: a systematic review.
    Breast Cancer. 2019 Mar 18. pii: 10.1007/s12282-019-00963.
    PubMed     Abstract available


  185. MENESES-SANCHEZ P, Garcia-Hernandez SC, Porchia LM, Perez-Fuentes R, et al
    C677T and A1298C methylenetetrahydrofolate reductase polymorphisms and breast cancer susceptibility among Latinos: a meta-analysis.
    Breast Cancer. 2019 Mar 15. pii: 10.1007/s12282-019-00961.
    PubMed     Abstract available


  186. FUKUI K, Masumoto N, Shiroma N, Kanou A, et al
    Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer.
    Breast Cancer. 2019 Mar 13. pii: 10.1007/s12282-019-00958.
    PubMed     Abstract available


  187. HIRAOKA E, Mimae T, Ito M, Kadoya T, et al
    Breast cancer cell motility is promoted by 14-3-3gamma.
    Breast Cancer. 2019 Mar 4. pii: 10.1007/s12282-019-00957.
    PubMed     Abstract available


    February 2019
  188. KOTANI H, Ito H, Kuwahara K, Kuzushima K, et al
    Impact of germinal center-associated nuclear protein polymorphisms on breast cancer risk and prognosis in a Japanese population.
    Breast Cancer. 2019 Feb 27. pii: 10.1007/s12282-019-00956.
    PubMed     Abstract available


  189. LAI HL, Chen CI, Lu CY, Yao YC, et al
    Relationships among personality, coping, and concurrent health-related quality of life in women with breast cancer.
    Breast Cancer. 2019 Feb 12. pii: 10.1007/s12282-019-00954.
    PubMed     Abstract available


  190. ISHIGURO H, Ohno S, Yamamoto Y, Takao S, et al
    Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer.
    Breast Cancer. 2019 Feb 7. pii: 10.1007/s12282-019-00952.
    PubMed     Abstract available


    January 2019
  191. BI Z, Liu J, Chen P, Liu Y, et al
    Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
    Breast Cancer. 2019 Jan 21. pii: 10.1007/s12282-018-00934.
    PubMed     Abstract available


  192. LIU L, Hu Y, Zhang S, Li X, et al
    Association of insulin-like growth factor 1 receptor and estrogen receptor with pathological complete response to neoadjuvant chemotherapy in HER2-negative breast cancer.
    Breast Cancer. 2019 Jan 8. pii: 10.1007/s12282-018-00939.
    PubMed     Abstract available


  193. UCHIUMI K, Tsuboi K, Sato N, Ito T, et al
    Cancer stem-like properties of hormonal therapy-resistant breast cancer cells.
    Breast Cancer. 2019 Jan 4. pii: 10.1007/s12282-018-00944.
    PubMed     Abstract available


  194. SHARMA R
    Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: evidence from Global Burden of Disease Study 2016.
    Breast Cancer. 2019 Jan 2. pii: 10.1007/s12282-018-00941.
    PubMed     Abstract available


    December 2018
  195. KHADEMALHOSSEINI M, Arababadi MK
    Toll-like receptor 4 and breast cancer: an updated systematic review.
    Breast Cancer. 2018 Dec 12. pii: 10.1007/s12282-018-00935.
    PubMed     Abstract available


    November 2018
  196. KANAYA N, Tanakaya K, Yamasaki R, Arata T, et al
    Clinicopathological features of breast cancer in Japanese female patients with Lynch syndrome.
    Breast Cancer. 2018 Nov 16. pii: 10.1007/s12282-018-0931.
    PubMed     Abstract available


  197. WANG R, Li J, Yin C, Zhao D, et al
    Identification of differentially expressed genes and typical fusion genes associated with three subtypes of breast cancer.
    Breast Cancer. 2018 Nov 16. pii: 10.1007/s12282-018-0924.
    PubMed     Abstract available


  198. ABBAS S, Siddique A, Shahid N, Khan RT, et al
    Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.
    Breast Cancer. 2018 Nov 14. pii: 10.1007/s12282-018-0932.
    PubMed     Abstract available


    October 2018
  199. HU K, He P, Peng Q, Zhong X, et al
    OFS plus AI or SERM vs. SERM alone in premenopausal women with hormone receptor-positive breast cancer: a prospective cohort study using the real-world database.
    Breast Cancer. 2018 Oct 26. pii: 10.1007/s12282-018-0929.
    PubMed     Abstract available


  200. DEN OUDEN MEM, Pelgrum-Keurhorst MN, Uitdehaag MJ, De Vocht HM, et al
    Intimacy and sexuality in women with breast cancer: professional guidance needed.
    Breast Cancer. 2018 Oct 25. pii: 10.1007/s12282-018-0927.
    PubMed     Abstract available


  201. RANGEL J, Tomas MT, Fernandes B
    Physical activity and physiotherapy: perception of women breast cancer survivors.
    Breast Cancer. 2018 Oct 25. pii: 10.1007/s12282-018-0928.
    PubMed     Abstract available


  202. YAGI T, Fujiishi K, Hasegawa A, Otsuka T, et al
    Aldehyde dehydrogenase 2 genotype in tolerability of alcohol contained in paclitaxel in Japanese breast cancer patients.
    Breast Cancer. 2018 Oct 22. pii: 10.1007/s12282-018-0918.
    PubMed     Abstract available


  203. LIU M, Zhou S, Wang J, Zhang Q, et al
    Identification of genes associated with survival of breast cancer patients.
    Breast Cancer. 2018 Oct 19. pii: 10.1007/s12282-018-0926.
    PubMed     Abstract available


  204. PALUMBO I, Mariucci C, Falcinelli L, Perrucci E, et al
    Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity.
    Breast Cancer. 2018 Oct 19. pii: 10.1007/s12282-018-0923.
    PubMed     Abstract available


  205. IIDA M, Tsuboi K, Niwa T, Ishida T, et al
    Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
    Breast Cancer. 2018 Oct 16. pii: 10.1007/s12282-018-0922.
    PubMed     Abstract available


  206. KWAPISZ D
    Oligometastatic breast cancer.
    Breast Cancer. 2018 Oct 15. pii: 10.1007/s12282-018-0921.
    PubMed     Abstract available


  207. TSURUTANI J, Sakata Y, Matsuoka T
    Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study.
    Breast Cancer. 2018 Oct 15. pii: 10.1007/s12282-018-0919.
    PubMed     Abstract available


  208. SUZUKI E, Sugimoto M, Kawaguchi K, Pu F, et al
    Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients.
    Breast Cancer. 2018 Oct 13. pii: 10.1007/s12282-018-0920.
    PubMed     Abstract available


  209. HASHEMI ZS, Forouzandeh Moghadam M, Khalili S, Ghavami M, et al
    Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy.
    Breast Cancer. 2018 Oct 3. pii: 10.1007/s12282-018-0915.
    PubMed     Abstract available


    September 2018
  210. WANG X, Jia M, Li Y, Bao Y, et al
    Validation of an information-motivation-behavioral skills model of upper limb functional exercise adherence among Chinese postoperative patients with breast cancer.
    Breast Cancer. 2018 Sep 27. pii: 10.1007/s12282-018-0911.
    PubMed     Abstract available


  211. NAKASHIMA K, Uematsu T, Takahashi K, Nishimura S, et al
    Does breast cancer growth rate really depend on tumor subtype? Measurement of tumor doubling time using serial ultrasonography between diagnosis and surgery.
    Breast Cancer. 2018 Sep 26. pii: 10.1007/s12282-018-0914.
    PubMed     Abstract available


  212. MA Y, Wang Y, Song B
    Griffipavixanthone induces apoptosis of human breast cancer MCF-7 cells in vitro.
    Breast Cancer. 2018 Sep 26. pii: 10.1007/s12282-018-0912.
    PubMed     Abstract available


  213. ZOHNY SF, Al-Malki AL, Zamzami MA, Choudhry H, et al
    p21(Waf1/Cip1): its paradoxical effect in the regulation of breast cancer.
    Breast Cancer. 2018 Sep 25. pii: 10.1007/s12282-018-0913.
    PubMed     Abstract available


  214. ISHIGAMI E, Sakakibara M, Sakakibara J, Masuda T, et al
    Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer.
    Breast Cancer. 2018 Sep 22. pii: 10.1007/s12282-018-0910.
    PubMed     Abstract available


  215. TALIMA S, Kassem H, Kassem N
    Correction to: Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.
    Breast Cancer. 2018 Sep 21. pii: 10.1007/s12282-018-0909.
    PubMed     Abstract available


  216. OKUMATSU K, Tsujimoto T, Wakaba K, Seki A, et al
    Correction to: Effects of a combined exercise plus diet program on cardiorespiratory fitness of breast cancer patients.
    Breast Cancer. 2018 Sep 17. pii: 10.1007/s12282-018-0902.
    PubMed     Abstract available


  217. KIKAWA Y, Hatachi Y, Rumpold G, Tokiwa M, et al
    Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.
    Breast Cancer. 2018 Sep 7. pii: 10.1007/s12282-018-0905.
    PubMed     Abstract available


  218. TALIMA S, Kaseem H, Kaseem N
    Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.
    Breast Cancer. 2018 Sep 6. pii: 10.1007/s12282-018-0904.
    PubMed     Abstract available


  219. ABU-KHALAF M, Muralikrishnan S, Hatzis C, Canchi D, et al
    Breast cancer patients with brain metastasis undergoing GKRS.
    Breast Cancer. 2018 Sep 4. pii: 10.1007/s12282-018-0903.
    PubMed     Abstract available


  220. AYGIN D, Cengiz H
    Life quality of patients who underwent breast reconstruction after prophylactic mastectomy: systematic review.
    Breast Cancer. 2018;25:497-505.
    PubMed     Abstract available


  221. SUGHAYER M, Alaaraj R, Alsughayer A
    Applying new Magee equations for predicting the Oncotype Dx recurrence score.
    Breast Cancer. 2018;25:597-604.
    PubMed     Abstract available


  222. SAKAMOTO N, Fukuma E, Tsunoda Y, Teraoka K, et al
    Evaluation of the dislocation and long-term sonographic detectability of a hydrogel-based breast biopsy site marker.
    Breast Cancer. 2018;25:575-582.
    PubMed     Abstract available


  223. ADACHI Y, Sawaki M, Hattori M, Yoshimura A, et al
    Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
    Breast Cancer. 2018;25:560-565.
    PubMed     Abstract available


  224. GORCZYNSKI RM, Erin N, Maqbool T, Gorczynski CP, et al
    Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions.
    Breast Cancer. 2018;25:547-559.
    PubMed     Abstract available


    August 2018
  225. AYGIN D, Bozdemir H
    Exposure to violence in breast cancer patients: systematic review.
    Breast Cancer. 2018 Aug 22. pii: 10.1007/s12282-018-0900.
    PubMed     Abstract available


  226. NAGASAKA K, Satake H, Ishigaki S, Kawai H, et al
    Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
    Breast Cancer. 2018 Aug 1. pii: 10.1007/s12282-018-0899.
    PubMed     Abstract available


    July 2018
  227. ALTUNDAG K
    Younger breast cancer patients under the age of 35 might have a better disease-free survival if they received ovarian function suppression more than 3 years.
    Breast Cancer. 2018 Jul 28. pii: 10.1007/s12282-018-0897.
    PubMed    


  228. NAKATSUKASA K, Koyama H, Ouchi Y, Ono H, et al
    Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results.
    Breast Cancer. 2018 Jul 27. pii: 10.1007/s12282-018-0896.
    PubMed     Abstract available


  229. AFTAB A, Shahzad S, Hussain HMJ, Khan R, et al
    CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis.
    Breast Cancer. 2018 Jul 23. pii: 10.1007/s12282-018-0894.
    PubMed     Abstract available


  230. NOGUCHI E, Tamura K, Hattori M, Horiguchi J, et al
    Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study.
    Breast Cancer. 2018 Jul 23. pii: 10.1007/s12282-018-0887.
    PubMed     Abstract available


  231. LIU C, Liu Y, Chen L, Zhang M, et al
    Quantitative proteome and lysine succinylome analyses provide insights into metabolic regulation in breast cancer.
    Breast Cancer. 2018 Jul 18. pii: 10.1007/s12282-018-0893.
    PubMed     Abstract available


  232. OKUMATSU K, Tsujimoto T, Wakaba K, Seki A, et al
    Effects of a combined exercise plus diet program on cardiorespiratory fitness of breast cancer patients.
    Breast Cancer. 2018 Jul 10. pii: 10.1007/s12282-018-0889.
    PubMed     Abstract available


  233. MA D, Chen C, Wu J, Wang H, et al
    Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Breast Cancer. 2018 Jul 5. pii: 10.1007/s12282-018-0891.
    PubMed     Abstract available


  234. TOKUNAGA E, Fujita A, Takizawa K, Baba K, et al
    CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Breast Cancer. 2018 Jul 3. pii: 10.1007/s12282-018-0888.
    PubMed     Abstract available


  235. MACHIDA Y, Shimauchi A, Igarashi T, Hoshi K, et al
    Preoperative breast MRI: reproducibility and significance of findings relevant to nipple-areolar complex involvement.
    Breast Cancer. 2018;25:456-463.
    PubMed     Abstract available


  236. SAIMURA M, Koga K, Anan K, Mitsuyama S, et al
    Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors.
    Breast Cancer. 2018;25:470-478.
    PubMed     Abstract available


    June 2018
  237. PENG X, Yan B, Shen Y
    MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
    Breast Cancer. 2018 Jun 27. pii: 10.1007/s12282-018-0881.
    PubMed     Abstract available


  238. LIU L, Yin B, Yi Z, Liu X, et al
    Breast cancer stem cells characterized by CD70 expression preferentially metastasize to the lungs.
    Breast Cancer. 2018 Jun 14. pii: 10.1007/s12282-018-0880.
    PubMed     Abstract available


  239. TAKABATAKE D, Kajiwara Y, Ohtani S, Itano Y, et al
    The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.
    Breast Cancer. 2018 Jun 11. pii: 10.1007/s12282-018-0877.
    PubMed     Abstract available


  240. TOYAMA T, Yoshimura A, Hayashi T, Kobayashi N, et al
    A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer.
    Breast Cancer. 2018 Jun 8. pii: 10.1007/s12282-018-0879.
    PubMed     Abstract available


    May 2018
  241. LOUHICHI T, Ziadi S, Saad H, Dhiab MB, et al
    Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
    Breast Cancer. 2018 May 29. pii: 10.1007/s12282-018-0875.
    PubMed     Abstract available


  242. SAJI S
    The long and winding road for overcoming resistance to hormone therapy in breast cancer.
    Breast Cancer. 2018 May 28. pii: 10.1007/s12282-018-0876.
    PubMed    


  243. GAO L, Li SC
    Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation.
    Breast Cancer. 2018 May 25. pii: 10.1007/s12282-018-0872.
    PubMed     Abstract available


  244. WEN L, Liu L, Wen L, Yu T, et al
    Artesunate promotes G2/M cell cycle arrest in MCF7 breast cancer cells through ATM activation.
    Breast Cancer. 2018 May 24. pii: 10.1007/s12282-018-0873.
    PubMed     Abstract available


  245. OSTAPCHUK YO, Perfilyeva YV, Kustova EA, Urazalieva NT, et al
    Functional heterogeneity of circulating T regulatory cell subsets in breast cancer patients.
    Breast Cancer. 2018 May 24. pii: 10.1007/s12282-018-0874.
    PubMed     Abstract available


  246. LEE SB, Sohn G, Kim J, Chung IY, et al
    Survival analysis according to period and analysis of the factors influencing changes in survival in patients with recurrent breast cancer: a large-scale, single-center study.
    Breast Cancer. 2018 May 21. pii: 10.1007/s12282-018-0869.
    PubMed     Abstract available


  247. TAKADA M, Takeuchi M, Suzuki E, Sato F, et al
    Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence.
    Breast Cancer. 2018 May 9. pii: 10.1007/s12282-018-0868.
    PubMed     Abstract available


  248. JAMAN MS, Sayeed MA
    Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives.
    Breast Cancer. 2018 May 3. pii: 10.1007/s12282-018-0866.
    PubMed     Abstract available


  249. GLOWACKA-MROTEK I, Sowa M, Nowikiewicz T, Siedlecki Z, et al
    Foot posture in female patients 5 years after breast-conserving surgery: a case-control study.
    Breast Cancer. 2018;25:325-333.
    PubMed     Abstract available


    April 2018
  250. KWAPISZ D
    Cyclin-dependent kinase 4/6 inhibitors in hormone receptor-positive early breast cancer: preliminary results and ongoing studies.
    Breast Cancer. 2018 Apr 26. pii: 10.1007/s12282-018-0864.
    PubMed     Abstract available


  251. SAKAI H, Tsurutani J, Iwasa T, Komoike Y, et al
    HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer.
    Breast Cancer. 2018 Apr 26. pii: 10.1007/s12282-018-0861.
    PubMed     Abstract available


  252. WANG NN, Yang ZJ, Wang X, Chen LX, et al
    A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients: a retrospective analysis and nomogram development.
    Breast Cancer. 2018 Apr 25. pii: 10.1007/s12282-018-0863.
    PubMed     Abstract available


  253. AOYAGI T, Takabe K, Tamanuki T, Matsubara H, et al
    Pseudocirrhosis after chemotherapy in breast cancer, case reports.
    Breast Cancer. 2018 Apr 25. pii: 10.1007/s12282-018-0865.
    PubMed     Abstract available


  254. OHASHI R, Nagao M, Nakamura I, Okamoto T, et al
    Improvement in diagnostic performance of breast cancer: comparison between conventional digital mammography alone and conventional mammography plus digital breast tomosynthesis.
    Breast Cancer. 2018 Apr 12. pii: 10.1007/s12282-018-0859.
    PubMed     Abstract available


  255. NAZARI SS, Mukherjee P
    An overview of mammographic density and its association with breast cancer.
    Breast Cancer. 2018 Apr 12. pii: 10.1007/s12282-018-0857.
    PubMed     Abstract available


  256. LI Q, Gao H, Zhou S, Liao Y, et al
    LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-beta1 and downregulating PHGDH.
    Breast Cancer. 2018 Apr 6. pii: 10.1007/s12282-018-0858.
    PubMed     Abstract available


  257. IWASE M, Sawaki M, Hattori M, Yoshimura A, et al
    Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery.
    Breast Cancer. 2018 Apr 4. pii: 10.1007/s12282-018-0856.
    PubMed     Abstract available


    March 2018
  258. SASADA S, Shien T, Iwata H
    Current status of postmastectomy radiation therapy in T1-2 breast cancer with limited positive lymph nodes in Japan: Japan Clinical Oncology Group Survey.
    Breast Cancer. 2018 Mar 23. pii: 10.1007/s12282-018-0855.
    PubMed    


  259. WAKABAYASHI H, Hamaguchi T, Nagao N, Kato S, et al
    Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line.
    Breast Cancer. 2018 Mar 19. pii: 10.1007/s12282-018-0853.
    PubMed     Abstract available


  260. ZHANG JM, Wei K, Jiang M
    OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
    Breast Cancer. 2018 Mar 13. pii: 10.1007/s12282-018-0844.
    PubMed     Abstract available


  261. YOSHIMURA A, Okumura S, Sawaki M, Hattori M, et al
    Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
    Breast Cancer. 2018 Mar 8. pii: 10.1007/s12282-018-0850.
    PubMed     Abstract available


  262. KA WH, Cho SK, Chun BN, Byun SY, et al
    The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
    Breast Cancer. 2018 Mar 7. pii: 10.1007/s12282-018-0849.
    PubMed     Abstract available


    February 2018
  263. RAMOS-ESQUIVEL A, Hernandez-Steller H, Savard MF, Landaverde DU, et al
    Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials.
    Breast Cancer. 2018 Feb 22. pii: 10.1007/s12282-018-0848.
    PubMed     Abstract available


  264. NOGUCHI S, Ellis MJ, Robertson JFR, Thirlwell J, et al
    Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON).
    Breast Cancer. 2018 Feb 15. pii: 10.1007/s12282-018-0838.
    PubMed     Abstract available


  265. MASUDA N, Toi M, Yamamoto N, Iwata H, et al
    Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicent
    Breast Cancer. 2018 Feb 14. pii: 10.1007/s12282-018-0839.
    PubMed     Abstract available


  266. CHEN W, Lv X, Xu X, Gao X, et al
    Meta-analysis for psychological impact of breast reconstruction in patients with breast cancer.
    Breast Cancer. 2018 Feb 13. pii: 10.1007/s12282-018-0846.
    PubMed     Abstract available


  267. OHTANI S, Nakayama T, Yoshinami T, Watanabe KI, et al
    Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
    Breast Cancer. 2018 Feb 12. pii: 10.1007/s12282-018-0843.
    PubMed     Abstract available


  268. SURYAVANSHI M, Mehta A, Jaipuria J, Kumar D, et al
    Clinical utility of RT-PCR in assessing HER 2 gene expression versus traditional IHC and FISH in breast cancer patients.
    Breast Cancer. 2018 Feb 9. pii: 10.1007/s12282-018-0840.
    PubMed     Abstract available


  269. ZOU L, Liu FH, Shen PP, Hu Y, et al
    The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Breast Cancer. 2018 Feb 3. pii: 10.1007/s12282-018-0830.
    PubMed     Abstract available


  270. IWATA H
    Clinical development of CDK4/6 inhibitor for breast cancer.
    Breast Cancer. 2018 Feb 1. pii: 10.1007/s12282-017-0827.
    PubMed     Abstract available


    January 2018
  271. WANG Y, Wang J, Long F, Wang N, et al
    Correlation of FANCM expression with clinical factors in luminal B breast cancer.
    Breast Cancer. 2018 Jan 31. pii: 10.1007/s12282-018-0841.
    PubMed     Abstract available


  272. KHAN RT, Siddique A, Shahid N, Khokher S, et al
    Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
    Breast Cancer. 2018 Jan 24. pii: 10.1007/s12282-018-0837.
    PubMed     Abstract available


  273. NGUYEN-THU H, Hanaoka H, Nakajima T, Yamaguchi A, et al
    Early prediction of triple negative breast cancer response to cisplatin treatment using diffusion-weighted MRI and (18)F-FDG-PET.
    Breast Cancer. 2018 Jan 22. pii: 10.1007/s12282-018-0834.
    PubMed     Abstract available


  274. OZAKI Y, Tanabe Y, Tamura N, Ogura T, et al
    Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study.
    Breast Cancer. 2018 Jan 22. pii: 10.1007/s12282-018-0836.
    PubMed     Abstract available


  275. YANG ZJ, Yu Y, Chi JR, Guan M, et al
    The combined pN stage and breast cancer subtypes in breast cancer: a better discriminator of outcome can be used to refine the 8th AJCC staging manual.
    Breast Cancer. 2018 Jan 20. pii: 10.1007/s12282-018-0833.
    PubMed     Abstract available


  276. HABYARIMANA T, Attaleb M, Mazarati JB, Bakri Y, et al
    Detection of human papillomavirus DNA in tumors from Rwandese breast cancer patients.
    Breast Cancer. 2018 Jan 19. pii: 10.1007/s12282-018-0831.
    PubMed     Abstract available


  277. INARI H, Shimizu S, Suganuma N, Yoshida T, et al
    Correction to: A comparison of clinicopathological characteristics and long-term survival outcomes between symptomatic and screen-detected breast cancer in Japanese women.
    Breast Cancer. 2018 Jan 10. pii: 10.1007/s12282-018-0832.
    PubMed     Abstract available


  278. PIVOT X, Im SA, Guo M, Marme F, et al
    Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine.
    Breast Cancer. 2018 Jan 4. pii: 10.1007/s12282-017-0826.
    PubMed     Abstract available


    December 2017
  279. PIERRISNARD C, Baciuchka M, Mancini J, Rathelot P, et al
    Body image and psychological distress in women with breast cancer: a French online survey on patients' perceptions and expectations.
    Breast Cancer. 2017 Dec 29. pii: 10.1007/s12282-017-0828.
    PubMed     Abstract available


  280. ATTALLAH AM, El-Far M, Abdelrazek MA, Omran MM, et al
    HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer.
    Breast Cancer. 2017 Dec 28. pii: 10.1007/s12282-017-0829.
    PubMed     Abstract available


  281. SHIMOI T, Yoshida M, Kitamura Y, Yoshino T, et al
    TERT promoter hotspot mutations in breast cancer.
    Breast Cancer. 2017 Dec 8. pii: 10.1007/s12282-017-0825.
    PubMed     Abstract available


  282. TSUDA B, Miyamoto A, Yokoyama K, Ogiya R, et al
    B-cell populations are expanded in breast cancer patients compared with healthy controls.
    Breast Cancer. 2017 Dec 4. pii: 10.1007/s12282-017-0824.
    PubMed     Abstract available


  283. DORFEL S, Steffens CC, Meyer D, Tesch H, et al
    Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study.
    Breast Cancer. 2017 Dec 4. pii: 10.1007/s12282-017-0823.
    PubMed     Abstract available


  284. HE J, Chen Y, Cai L, Li Z, et al
    UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer.
    Breast Cancer. 2017 Dec 1. pii: 10.1007/s12282-017-0820.
    PubMed     Abstract available


    November 2017
  285. INOUE H, Horii R, Ito Y, Iwase T, et al
    Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer.
    Breast Cancer. 2017 Nov 28. pii: 10.1007/s12282-017-0822.
    PubMed     Abstract available


  286. ZHANG ZL, Jiang QC, Wang SR
    Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Breast Cancer. 2017 Nov 27. pii: 10.1007/s12282-017-0821.
    PubMed     Abstract available


  287. ZHAO Q, Song W, He DY, Li Y, et al
    Identification of key gene modules and pathways of human breast cancer by co-expression analysis.
    Breast Cancer. 2017 Nov 23. pii: 10.1007/s12282-017-0817.
    PubMed     Abstract available


  288. HATTORI M, Ishiguro H, Masuda N, Yoshimura A, et al
    Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study.
    Breast Cancer. 2017 Nov 20. doi: 10.1007/s12282-017-0815.
    PubMed     Abstract available


  289. KASSEM L, Shohdy KS, Lasheen S, Abdel-Rahman O, et al
    Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis.
    Breast Cancer. 2017 Nov 16. doi: 10.1007/s12282-017-0818.
    PubMed     Abstract available


  290. WANG R, Li J, Zhao Y, Li Y, et al
    Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis.
    Breast Cancer. 2017 Nov 14. doi: 10.1007/s12282-017-0816.
    PubMed     Abstract available


  291. ADHAMI M, Haghdoost AA, Sadeghi B, Malekpour Afshar R, et al
    Candidate miRNAs in human breast cancer biomarkers: a systematic review.
    Breast Cancer. 2017 Nov 3. doi: 10.1007/s12282-017-0814.
    PubMed     Abstract available


  292. SHIGEMATSU H, Ozaki S, Yasui D, Zaitsu J, et al
    Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer.
    Breast Cancer. 2017 Nov 1. doi: 10.1007/s12282-017-0811.
    PubMed     Abstract available


  293. HARAO M, Ando J, Kamata H, Hoshi N, et al
    Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review.
    Breast Cancer. 2017 Nov 1. doi: 10.1007/s12282-017-0813.
    PubMed     Abstract available


    October 2017
  294. ARAKI K, Miyoshi Y
    Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer.
    Breast Cancer. 2017 Oct 31. doi: 10.1007/s12282-017-0812.
    PubMed     Abstract available


  295. KHPAL M, Miller JRC, Petrovic Z, Hassanally D, et al
    Local anesthetic delivery via surgical drain provides improved pain control versus direct skin infiltration following axillary node dissection for breast cancer.
    Breast Cancer. 2017 Oct 26. doi: 10.1007/s12282-017-0810.
    PubMed     Abstract available


  296. REGEV-AVRAHAM Z, Baron-Epel O, Hammond SK, Keinan-Boker L, et al
    Passive smoking, NAT2 polymorphism, and breast cancer risk in Israeli Arab women: a case-control study.
    Breast Cancer. 2017 Oct 26. doi: 10.1007/s12282-017-0809.
    PubMed     Abstract available


  297. OGITA M, Nagura N, Kawamori J, In R, et al
    Risk factors for complications among breast cancer patients treated with post-mastectomy radiotherapy and immediate tissue-expander/permanent implant reconstruction: a retrospective cohort study.
    Breast Cancer. 2017 Oct 19. doi: 10.1007/s12282-017-0808.
    PubMed     Abstract available


  298. TOYODA Y, Tabuchi T, Nakayama T, Hojo S, et al
    Trends in the clinical stage distribution of breast cancer in Osaka, Japan.
    Breast Cancer. 2017 Oct 12. doi: 10.1007/s12282-017-0807.
    PubMed     Abstract available


    September 2017
  299. ALTUNDAG K
    Questions about lower inner zone tumors in early-stage breast cancer.
    Breast Cancer. 2017 Sep 14. doi: 10.1007/s12282-017-0801.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: